# Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies

> **NCT00413686** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 42 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** AZD7762
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00413686
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2010-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413686, "Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00413686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*